logo
  

GEO Issues Q2 Outlook; Lifts FY21 AFFO View, Cuts Revenue Forecast - Quick Facts

While reporting higher profit and weak revenues in its first quarter, GEO Group, Inc. (GEO), a real estate investment trust, issued financial outlook for the second quarter and updated fiscal year 2021 forecast.

For the second quarter 2021, the company expects attributable net income in a range of $35 million to $38 million, adjusted funds from operations or AFFO in a range of $0.57 to $0.59 per share, and revenues in a range of $558 million to $563 million.

On average, analysts polled by Thomson Reuters expect earnings of $0.22 per share on revenues of $570.8 million. Analysts' estimates typically exclude special items.

Further, for the full year 2021, the company now expects attributable net income in a range of $141 million to $150 million, adjusted net income per share to be in a range of $1.02 to $1.10, AFFO in a range of $2.23 to $2.31 per share, and revenues in a range of $2.23 billion to $2.25 billion.

For the full year 2021, GEO previously expected attributable net income in a range of $0.88 to $0.98 per share, AFFO in a range of $1.98 to $2.08 per share, and revenues in a range of about $2.24 billion to $2.27 billion.

The Street expects the company to report earnings of $0.92 per share for the year on revenues of $2.27 billion.

The company said the updated guidance continues to assume a slow recovery from the COVID-19 pandemic throughout 2021.

In pre-market activity on NYSE, GEO shares were gaining 2.4 percent to trade at $5.88.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Activity in the U.S. manufacturing sector slowed by more than expected in the month of September but still saw continued growth, according to a report released by the Institute for Supply Management on Monday. Stocks have moved sharply higher in morning trading on Monday, regaining ground following a dismal September. The major averages have all shown substantial moves to the upside. Swedish geneticist Svante Paabo has won this year's Nobel Prize in Physiology/Medicine for his discoveries concerning the genomes of extinct hominins and human evolution. Through his pioneering research, Svante Pääbo accomplished something seemingly impossible: sequencing the genome of the Neanderthal, an extinct relative of present-day humans. He also made the sensational discovery of a previous
RELATED NEWS
Follow RTT